NEA Management Company, LLC - TRILLIUM THERAPEUTICS INC ownership

TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 116 filers reported holding TRILLIUM THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.74 and the average weighting 0.6%.

Quarter-by-quarter ownership
NEA Management Company, LLC ownership history of TRILLIUM THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$100,731,000
+81.0%
5,736,3630.0%1.20%
+65.1%
Q2 2021$55,643,000
-9.7%
5,736,3630.0%0.72%
-47.6%
Q1 2021$61,609,000
-27.0%
5,736,3630.0%1.38%
-37.9%
Q4 2020$84,382,000
+3.5%
5,736,3630.0%2.23%
-35.4%
Q3 2020$81,514,000
+75.7%
5,736,3630.0%3.45%
+84.9%
Q2 2020$46,407,000
+100.2%
5,736,3630.0%1.87%
+54.1%
Q1 2020$23,175,000
+971.4%
5,736,363
+173.2%
1.21%
+1087.3%
Q4 2019$2,163,000
+234.8%
2,100,0000.0%0.10%
+92.5%
Q3 2019$646,000
-6.5%
2,100,0000.0%0.05%
+10.4%
Q2 2019$691,000
-50.1%
2,100,0000.0%0.05%
-33.3%
Q1 2019$1,386,000
-35.2%
2,100,000
+68.0%
0.07%
-15.3%
Q4 2018$2,138,000
-70.5%
1,250,0000.0%0.08%
-72.8%
Q3 2018$7,250,000
-3.3%
1,250,0000.0%0.31%
-10.8%
Q2 2018$7,500,000
-16.7%
1,250,0000.0%0.35%
-12.2%
Q1 2018$9,000,000
-0.7%
1,250,0000.0%0.40%
+6.7%
Q4 2017$9,063,000
+67.6%
1,250,000
+19.0%
0.38%
+98.4%
Q3 2017$5,408,000
+17.1%
1,050,0000.0%0.19%
+12.5%
Q2 2017$4,619,0001,050,0000.17%
Other shareholders
TRILLIUM THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
VR Adviser, LLC 4,040,000$59,428,0008.74%
Fairmount Funds Management LLC 1,478,181$21,744,0007.78%
COMMODORE CAPITAL LP 852,871$12,546,0006.82%
Ghost Tree Capital, LLC 1,950,000$28,685,0006.39%
Endurant Capital Management LP 655,741$9,646,0003.48%
FRAZIER MANAGEMENT LLC 3,053,107$44,879,0003.46%
ACUTA CAPITAL PARTNERS, LLC 803,000$11,812,0003.21%
NEA Management Company, LLC 5,736,363$84,382,0002.23%
Tri Locum Partners LP 296,838$4,366,0001.59%
Avidity Partners Management LP 3,185,200$46,854,0001.52%
View complete list of TRILLIUM THERAPEUTICS INC shareholders